PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Mar-2024 OncoZenge Explores Strategic Options for BupiZenge™ in China OncoZenge
11-Mar-2024 Acquisition Builds Aspire’s Strategic Commitment Aspire Pharma Limited
11-Mar-2024 Acquisition Builds Aspire’s Strategic Commitment Aspire Pharma Limited
11-Mar-2024 Angelini Pharma launches challenge to improve target identification in epilepsy Wazoku
11-Mar-2024 FYB201/Ranibizumab keeps gaining momentum with approvals and launches in the MENA region Formycon AG
08-Mar-2024 Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer Curium
08-Mar-2024 Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update Kuros Biosciences AG
07-Mar-2024 Invitation to MorphoSys’ Full Year Results 2023 Conference Call on March 14, 2024 MorphoSys AG
07-Mar-2024 Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend Drägerwerk AG & Co. KGaA
07-Mar-2024 Evolva Holding SA in liquidation: Nice & Green requests 3 agenda items be included in AGM agenda Evolva Holding SA
07-Mar-2024 Shareholder Nice & Green SA requests 3 agenda items to be included in the agenda of the upcoming Annual General Meeting; shareholder Pegasus Global Opportunity Fund Ltd crosses 10% threshold Evolva Holding SA
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity at Headquarters with Two New Purpose-Built Facilities Almac Group
06-Mar-2024 Women in Life Science Denmark (WiLD) to host network meeting in collaboration with DANISH BIO to promote equity in the Danish life science industry Women in Life Science Denmark (WiLD)
06-Mar-2024 iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024 iTeos Therapeutics, Inc.
06-Mar-2024 Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting GSK
06-Mar-2024 Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery Elsevier
06-Mar-2024 Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024 Heidelberg Pharma AG
06-Mar-2024 Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic Evotec SE
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions